XELLIA PHARMACEUTICALS AS

0380 OSLO

Finances

Share Ownership

Return on Equity

7,91 %

Current Ratio

11,39

Debt-to-Equity Ratio

0,01

Key figures (NOK)	2022	2021	2020	2019
Revenue	88 993 000	73 253 000	81 520 000	76 651 000
Net Income	52 097 000	18 676 000	13 079 000	25 319 000
Total Assets	680 840 000	626 110 000	619 813 000	600 322 000
Total Equity	658 544 000	606 370 000	586 757 000	573 002 000

Income (NOK)	2022	2021	2020	2019
Revenue	88 993 000	73 253 000	81 520 000	76 651 000
Expenditure	82 043 000	68 965 000	76 256 000	71 755 000
Operating Profit	6 950 000	4 288 000	5 264 000	4 896 000
Financial Income	45 150 000	14 683 000	12 848 000	20 442 000
Financial Costs	3 000	295 000	5 033 000	19 000
Financial Balance	45 147 000	14 388 000	7 815 000	20 423 000
Earnings Before Tax	52 097 000	18 676 000	13 079 000	25 319 000
Tax	0	0	0	0
Net Income	52 097 000	18 676 000	13 079 000	25 319 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	467 799 000	445 835 000	443 409 000	450 522 000
Total Current Assets	213 041 000	180 275 000	176 404 000	149 800 000
Total Assets	680 840 000	626 110 000	619 813 000	600 322 000
Total Retained Equity	0	0	0	0
Total Equity	658 544 000	606 370 000	586 757 000	573 002 000
Total Long-Term Debt	3 598 000	3 839 000	5 012 000	6 129 000
Total Current Debt	18 698 000	15 901 000	28 044 000	21 191 000
Total Equity and Debt	680 840 000	626 110 000	619 813 000	600 322 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	88 993 000	73 253 000	81 520 000	0
Other Income	0	0	0	76 651 000
Revenue	88 993 000	73 253 000	81 520 000	76 651 000
Cost of Goods Sold	0	0	0	0
Salary Costs	54 333 000	46 025 000	51 377 000	46 710 000
Depreciation	6 396 000	6 242 000	5 980 000	5 795 000
Impairment	0	0	0	0
Expenditure	82 043 000	68 965 000	76 256 000	71 755 000
Operating Profit	6 950 000	4 288 000	5 264 000	4 896 000
Financial Income	45 150 000	14 683 000	12 848 000	20 442 000
Financial Costs	3 000	295 000	5 033 000	19 000
Financial Balance	45 147 000	14 388 000	7 815 000	20 423 000
Dividends	0	0	0	0
Net Income	52 097 000	18 676 000	13 079 000	25 319 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	8 962 000	12 125 000	15 288 000
Machinery and Plant Facilities	22 059 000	19 421 000	19 392 000	18 252 000
Fixtures	0	0	0	0
Total Tangible Assets	22 059 000	28 383 000	31 517 000	33 540 000
Total Fiancial Fixed Assets	445 740 000	417 452 000	411 892 000	416 982 000
Total Fixed Assets	467 799 000	445 835 000	443 409 000	450 522 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	198 986 000	175 475 000	166 448 000	142 250 000
Total Current Assets	213 041 000	180 275 000	176 404 000	149 800 000
Total Assets	680 840 000	626 110 000	619 813 000	600 322 000
Total Equity	658 544 000	606 370 000	586 757 000	573 002 000
Short-Term Group Debt	116 000	106 000	299 000	96 000
Total Long-Term Debt	3 598 000	3 839 000	5 012 000	6 129 000
Creditors	3 136 000	3 901 000	3 557 000	2 736 000
Unpaid Taxes	3 603 000	3 545 000	3 386 000	3 347 000
Dividends	0	0	0	0
Other Current Debt	11 843 000	8 349 000	20 802 000	15 012 000
Total Current Debt	18 698 000	15 901 000	28 044 000	21 191 000
Total Equity and Debt	680 840 000	626 110 000	619 813 000	600 322 000

Financial indicators	2022	2021	2020	2019
Return on Equity	7,91 %	3,08 %	2,23 %	4,42 %
Debt-to-Equity Ratio	0,01	0,01	0,01	0,01
Operating Profit Margin	7,81 %	5,85 %	6,46 %	6,39 %
Current Ratio	11,39	11,34	6,29	7,07
Quick Ratio	11,39	11,34	6,29	7,07
Equity Ratio	0,97	0,97	0,95	0,95
Gross Profit Margin	100 %	100 %	100 %	100 %